Sr Manager IT Business Applications at Legend Biotech

Ghent, Flanders, Belgium

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotech, BiopharmaIndustries

Requirements

Bachelor’s degree (or higher) in a relevant field such as Information Technology, Engineering, Computer Science, or similar
Minimum of ten years of experience in a similar role within a cGMP environment, preferably in a BioTech / BioPharma company
Strong technical knowledge of IT applications such as SAP, MES, LIMS, and others
Strong communication skills: assertive, with willingness to drive conversations and find common ground
Ability to build deep understanding of business challenges and processes
Fluent in English, with the ability to collaborate effectively across teams and functions
Nice to have: Knowledge of Dutch

Responsibilities

Serve as the first contact for all business application support and needs, providing alignment, guidance, and clarity during strategic plan rollouts
Manage stakeholders: Ensure alignment across IT teams in the US, EU, and with external partners; keep stakeholders informed and focused on shared goals and responsibilities
Drive strategic implementation: Build strong relationships with business stakeholders, gain deep understanding of the manufacturing environment, and help achieve key milestones
Lead project delivery: Oversee system enhancements, upgrades, and validation activities across platforms such as SAP S/4HANA, MES, QMS, and others
Manage direct reports (2-3): Help team members develop skills, provide clear expectations, support achievement of targets, and offer necessary support

Skills

SAP S/4HANA

MES

QMS

LIMS

SAP

cGMP

Stakeholder Management

Project Delivery

Legend Biotech

Develops and commercializes cell therapies

About Legend Biotech

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Franklin Township, New JerseyHeadquarters

2014Year Founded

$146.4MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options

Risks

Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.

Collaboration with Multiply Labs may face technological challenges, delaying production timelines.

Financial strain from new R&D facility could affect operational focus if advancements lag.

Differentiation

Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.

The company is technology agnostic, exploring multiple platforms for effective cancer treatments.

Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Upsides

Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.

New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.

Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

Land your dream remote job 3x faster with AI

Try Jobo Free